Paris / Bondy / Cary / Lyon / Basel / Marseille / Cochin / Courtaboeuf / Emeryville / Chatillon / subSaharan Africa / Colombes / Nice / Toulouse / Lille / Chicago / /
Company
SAS Institute Inc / Chiron Corp / M184V Mutation / Congenital Anomalies Working Group / Drug Resistance Genotypes Genotyping / LamivudineZidovudine Group / Fondation de France / Quiagen Ltd / Fiscus SA / Bristol-Myers Squibb / Dell / AIDS Clinical Trial Group / Pfizer / Dupont / Perinatal HIV Guidelines Working Group / /
Continent
Europe / Africa / North America / /
Country
Switzerland / France / United Kingdom / Finland / United States / /
Currency
USD / / /
Event
M&A / Product Recall / Product Issues / /
Facility
Port Royal / /
IndustryTerm
intervention / multivariable analysis accounting / control / imaging / sequence navigator software / historical control / /
Adverse Effects Validation Committee / Department of Internal Medicine / Department of ObstetricsGynecology / Institut National / Data and Safety Monitoring Board / Institut Mutualiste Montsouris / Sidaction Fund / national drug agency / LAMIVUDINE-ZIDOVUDINE AND MATERNAL HIV-1 TRANSMISSION mission / Public Health Service Task Force / ANRS / American Medical Association / Scientific Committee / Hopital Biceˆtre-Pharmacie Centrale / Lamivudine administration / Department of Obstetrics-Gynecology / /
Person
Christine Rouzioux / Jean Louis Be´nifla / Jean Verdier / Alain Berrebi / B. Clavier / V / Mandelbrot / Robert Debre / Marie-Jeanne Mayaux / Nicole Ciraru-Vigneron / Marianne Burgard / Marie-Laure Chaix / Aline Landreau-Mascaro / Eric Lachassine / Catherine Crenn-He / Louis Be / Blanche / Delfraissy / E. Lachassine / V / Louis Mourier / Bongain / F. David Ouaknine / Claire Rekacewicz / Guillaume Walkenaer / /